Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis

Journal of Clinical Virology

Volumn 58, Issue 1, 2013, Pages 321-324

  Burrel, Sonia ^a,b   Boutolleau, David ^a,b   Azar, Georges ^c,d   Doan, Serge ^c,d   Deback, Claire ^e,f   Cochereau, Isabelle ^c,d   Agut, Henri ^a,b   Gabison, Eric E ^c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d Service d'Ophtalmologie   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f Universite Paris Sud   (France)

Author keywords

Herpetic keratitis; Immunocompetent patient; Phenotypic and genotypic antiviral resistance assay; Resistance to acyclovir

Indexed keywords

ACICLOVIR; CORTICOSTEROID; CYCLOSPORIN A; STEROID; VALACICLOVIR;

AGED; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BEST CORRECTED VISUAL ACUITY; BINDING SITE; BLURRED VISION; CASE REPORT; CORNEA EDEMA; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENDOTHELIUM LESION; EYE EXAMINATION; EYE REDNESS; FOLLOW UP; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RECURRENT INFECTION; SLIT LAMP; VISUAL ACUITY;

EID: 84881491354     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.05.001     Document Type: Article

References (14)

1. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
2. Knickelbein J.E., Hendricks R.L., Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidenced-based review. Surv Ophthalmol 2009, 54:226-234.
3. Piret J., Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 2010, 55:459-472.
4. Duan R., de Vries R.D., Osterhaus A.D., Remeijer L., Verjans G.M. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 2008, 198:659-663.
5. Burrel S., Deback C., Agut H., Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother 2010, 54:4833-4842.
6. Huynh T.H., Johnson M.W., Comer G.M., Fish D.N. Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol 2008, 145:682-686.
7. Burrel S., Bonnafous P., Hubacek P., Agut H., Boutolleau D. Impact of novel mutations of herpes simplex virus type 1 and 2 thymidins kinases on acyclovir kinase activity. Antiviral Res 2012, 96:386-390.
8. Duan R., de Vries R.D., van Dun J.M., van Loenen F.B., Osterhaus A.D., et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009, 200:1402-1414.
9. van Velzen M., van Loenen F.B., Meesters R.J., de Graaf M., Remeijer L., Luider T.M., et al. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals. J Infect Dis 2012, 205:1539-1543.
10. Chibo D., Druce J., Sasadeusz J., Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res 2004, 61:83-91.
11. Bodhagi B., Mougin C., Michelson S., Agut H., Dighiero P., Offret H., et al. Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene. Exp Eye Res 2000, 71:353-359.
12. Zhang W., Suzuki T., Shiraishi A., Shimamura I., Inoue Y., Ohashi Y. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation. Cornea 2007, 26:105-106.
13. Sarisky R.T., Cano R., Nguyen T.T., Wittrock R.J., Duffy K.E., Clark P., et al. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir. Clin Infect Dis 2001, 33:2034-2039.
14. Hwang Y.T., Zuccola H.J., Lu Q., Hwang C.B. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity. J Virol 2004, 78:650-657.